Neal Bhatia

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Venues

Dermatology and therapy

American journal of clinical dermatology

The Journal of dermatological treatment

Therapeutics Clinical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Therapeutics Clinical Research Feb 01 2014

United States

Director of Clinical Dermatology

Publications

Neal Bhatia, Jayme Heim, J Gabriel Vasquez, Tina Bhutani, Brad Schenkel, Ranga Gogineni, John Koo
Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting. The Journal of dermatological treatment 35 (1) (2024)
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatology and therapy 14 (4) (2024)
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatology and therapy 14 (4) (2024)
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatology and therapy (2024)
Erica Montano, Neal Bhatia, Jelena Ostojić
Biomarkers in Cutaneous Keratinocyte Carcinomas. Dermatology and therapy (2024)
Erica Montano, Neal Bhatia, Jelena Ostojić
Biomarkers in Cutaneous Keratinocyte Carcinomas. Dermatology and therapy 14 (8) (2024)
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatology and therapy 14 (4) (2024)
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatology and therapy 14 (4) (2024)
Erica Montano, Neal Bhatia, Jelena Ostojić
Biomarkers in Cutaneous Keratinocyte Carcinomas. Dermatology and therapy 14 (8) (2024)
Erica Montano, Neal Bhatia, Jelena Ostojić
Biomarkers in Cutaneous Keratinocyte Carcinomas. Dermatology and therapy 14 (8) (2024)
Andrew Blauvelt, Melinda J Gooderham, Neal Bhatia, Richard G Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, Jonathan Ian Silverberg
Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3. Dermatology and therapy 12 (11) (2022)
Dillon J Patel, Neal Bhatia
Oral Antibiotics for Acne. American journal of clinical dermatology 22 (2) (2021)

Neal Bhatia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Neal Bhatia